The Biotechnology Innovation Organization (BIO) today announced that nine emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2018 BIO World Congress on Industrial Biotechnology.
BIO’s GreenTech Investor Sessions provide high visibility to early stage emerging industrial biotechnology companies developing advanced biofuels and renewable chemical platforms to share their new technologies and value proposition through formal 15-minute presentations to an elite audience of investors and analysts. Companies were selected to present breakthrough technologies, bio-based consumer product strategies, proofs of concept, and extensive intellectual property coverage during this session.
The GreenTech Investor Sessions and panel will take place Tuesday, July 17. The panel discussion will take place 9:10 – 10 a.m. and will be moderated by Roger Wyse, PhD, managing partner at Spruce Capital Partners. Panelists include:
- Neil Cameron, PhD, Investment Director, Advanced Materials, Emerald Technology Ventures
- Ganesh Kishore, PhD, Managing Partner, Spruce Capital Partners
- Emily Landsburg, Director, Ultra Capital
- Bill Lese, Managing Partner, Braemar Energy Ventures
- Jenny Rooke, PhD, Managing Partner, Genoa Ventures
- Jason Webber, Principal, Sustainable Conversion Ventures
GreenTech Investor Sessions will take place starting at 8:30 a.m. and will continue intermittently to 3:40 p.m. Companies presenting in GreenTech Investor Sessions include:
- Biomere Tech
- DMC Biotechnologies, Inc.
- Global Bioenergies
- Kalion, Inc.
- Leaf Resources Limited
- Oxford Biotrans Limited
- Steeper Energy
- Syngulon
- Triton Algae Innovations
For more information about companies presenting at GreenTech Investor Sessions at the 2018 BIO World Congress, please visit https://www.bio.org/events/greentech-investor-sessions.
Also, new at the 2018 BIO World Congress are company and technical presentations, taking place throughout the conference. More than 50 companies will be sharing their story, pipelines and objectives with BIO World Congress attendees in the education hall of the Pennsylvania Convention Center. For more information and to view a list of all presenting companies, visit https://www.bio.org/events/company-and-technical-presentations.
All programs and sessions at the 2018 BIO World Congress on Industrial Biotechnology are open to members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.
For more information on the conference, please visit https://www.bio.org/worldcongress. For assistance, please contact worldcongress@bio.org.
About BIO
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
View source version on businesswire.com: https://www.businesswire.com/news/home/20180627006260/en
/
Contacts
Biotechnology Innovation Organization (BIO)
Connor McKoy, 202-312-9288
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech
Source: Biotechnology Innovation Organization (BIO)